Edex and Facial paralysis - a phase IV clinical study of FDA data
We study 8,074 people who take Edex or have Facial paralysis. No report of Facial paralysis is found in people who take Edex.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Edex?
Edex has active ingredients of alprostadil. eHealthMe is studying from 460 Edex users for its effectiveness, alternative drugs and more.
What is Facial Paralysis?
Facial paralysis (loss of function of face muscle) is found to be associated with 1,508 drugs and 911 conditions by eHealthMe.
Do you take Edex and have Facial paralysis?Check whether Facial paralysis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Facial paralysis and when was it recovered:
Expand to all the drugs that have ingredients of alprostadil:
Alternative drugs to, pros and cons of Edex:
- Edex (460 reports)
Facial paralysis treatments and more:
- Facial paralysis (7,614 reports)
COVID vaccines that are related to Facial paralysis:
- Facial paralysis in Moderna COVID Vaccine
- Facial paralysis in Pfizer BioNTech Covid Vaccine
- Facial paralysis in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Facial paralysis:
All the conditions that are associated with Facial paralysis:
How the study uses the data?
The study uses data from the FDA. It is based on alprostadil (the active ingredients of Edex) and Edex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Propylthiouracil and Feeling Of Body Temperature Change - a second ago
- Bisoprolol Fumarate and Irritability - 3 seconds ago
- Cefoxitin and Urinary Tract Infection - 9 seconds ago
- Tarceva and Horizant drug interaction - 9 seconds ago
- Pyrazinamide and Ards (Acute Respiratory Distress Syndrome) - 12 seconds ago
- Lantus and White Blood Cells Urine Positive - 19 seconds ago
- Dalmane vs. L - Tryptophan - 19 seconds ago
- Lotensin and Ulcer Haemorrhage - 19 seconds ago
- Torsemide and Application Site Pain - 20 seconds ago
- Zantac and Intracardiac Mass - 21 seconds ago